Clinical Trials Browser

Non-Small Cell Lung Cancer Metastatic

Carcinoma, Transitional Cell, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Lung Neoplasms

Non-Small Cell Lung Cancer Metastatic

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

Non-small Cell Carcinoma

Metastatic Non-small Cell Lung Cancers

Meningeal Carcinomatosis

Mesothelioma, Malignant

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer

Mesothelioma

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

Lung Neoplasms

Non-squamous Non-small-cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Clinical Trials

ANTELOPE

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

NIRVANA-LUNG

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Plasma-Adapted First-Line Pembro In NSCLC

FLAME

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

STAGGER

MP-ALK

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

TOP

AMIGO-1

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NIVIPI-Brain

Afatinib With CT and RT for EGFR-Mutant NSCLC

Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC